In 2022, Fannin has partnered with Nova Biomedical (US) to set a new standard on whole blood, point-of-care and critical care analyzers. Nova Biomedical has been a worldwide leader in manufacturing and the development of these state-of-the-art instruments. Nova Biomedical is also incorporated with the biotech industry, creating some of the most advanced instruments for cell culture monitoring.
Nova is one of the fastest growing in vitro diagnostic companies in the world, and the Prime Plus is no exception to this legacy.
The Prime Plus Blood Gas Analyser combines the revolutionary microelectronics of the consumer world with Nova Biomedical’s innovative MicroSensor Card™ technology for a smaller, faster, more powerful yet simpler and less expensive analyzer.
To order the Prime Plus click here